CompletedNCT02841865
Radiological Response of Pancreatic Neuroendocrine Tumors: Comparison Between the Choi and the RECIST Criteria
Studying Neuroendocrine neoplasm of pancreas
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Grupo Espanol de Tumores Neuroendocrinos
- Principal Investigator
- María del Pilar Solís Hernández, M.D.Hospital Universitario Central de Asturias
- Enrollment
- 104 enrolled
- Eligibility
- All sexes
- Timeline
- 2015 – 2018
Study locations (10)
- Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain
- Hospital Universitari Vall d'Hebron, Barcelona, Spain
- Hospital Universitario 12 de Octubre, Madrid, Spain
- Hospital Universitario La Paz, Madrid, Spain
- Hospital Universitario Ramón y Cajal, Madrid, Spain
- Hospital Universitario Morales Meseguer, Murcia, Spain
- Hospital Universitario Central de Asturias, Oviedo, Spain
- Complejo Hospitalario de Navarra, Pamplona, Spain
- Hospital Universitario Virgen del Rocio, Seville, Spain
- Hospital Universitario Miguel Servet, Zaragoza, Spain
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02841865 on ClinicalTrials.govOther trials for Neuroendocrine neoplasm of pancreas
Additional recruiting or active studies for the same condition.